Using a mouse model, Mauer et al. [109] demonstrated that IL-6 plays a homeostatic role in limiting obesity-associated insulin resistance and inflammation by reducing proinflammatory gene expression and increasing IL-4 responsiveness in macrophages [109]. The gene discussed is IL6; the disease is Insulin resistance.